OneTwenty develops intelligence software for insulin pumps, smart pens, and other medical devices.
Founded in 2018 and based in Zurich, Switzerland, OneTwenty develops bioX, an intelligence system for insulin pumps, smart pens, and other medical devices. Its tools support insulin therapy, health data predictions, and sensor data processing. In January 2024, Dieter von Holtzbrinck Ventures led a venture funding round, with Tiny Super Computer Investment Company participating. The company planned to use the funds to scale its technology and continue product development.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in